Mister Miller advocates for regulating hemp products to protect children in Tennessee

In a recent meeting of the U.S. House Committee on Oversight and Government Reform, a pressing issue took center stage: the need to restore trust in the Food and Drug Administration (FDA) by addressing the growing concern over illicit hemp products. The discussion highlighted the confusion surrounding the distinction between hemp and marijuana, particularly regarding products containing intoxicating cannabinoids.

One speaker, a representative from East Tennessee, shared a personal anecdote about visiting a local hemp store, where he was confronted with questions about his stance on hemp products that contain delta-9 THC. He emphasized that while his support extends to products with less than 0.3% THC, there is a critical need for strict regulation. Alarmingly, he revealed that East Tennessee Children's Hospital reported cases of newborns and children being exposed to THC products, underscoring the urgency of the situation.

The representative expressed deep concern over the lack of regulation, stating, "Kids are ending up at the hospital," and called for increased public education on the risks associated with these products. He noted that while states like Tennessee and Kentucky are making strides to regulate hemp products, federal support is essential to effectively tackle the issue.

The conversation also touched on the broader implications of adult use of hemp products. The representative acknowledged that when used responsibly, these products can serve as beneficial health alternatives for adults. However, he firmly stated that the safety of children must remain a priority, urging the government to step in and help regulate the industry.

As the meeting concluded, the message was clear: without robust federal oversight, the risks associated with hemp products, particularly for children, will continue to pose a significant challenge. The call for action resonated throughout the room, leaving attendees with a sense of urgency to address this critical public health issue.